Upcoming Events

More events are coming soon.

Past Events

Jun 3 - Jun 7, 2022
ASCO Conference

Poster title: GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non-small cell lung cancer (NSCLC) – a randomized double-blind trial

Poster title: Resistance to anti-PD-1/anti-PD-L1: GB1211 reverses galectin-3 induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1

https://beta.asco.org/
May 13 - May 18, 2022
ATS 2022

Poster title: DEFINE - a Randomized, Open-Label Trial of the Inhaled Galectin-3 Inhibitor GB0139 in Hospitalized Patients with Moderate-to-Severe COVID-19

https://conference.thoracic.org/